vs
Side-by-side financial comparison of Dexcom (DXCM) and Ovintiv Inc. (OVV). Click either name above to swap in a different company.
Ovintiv Inc. is the larger business by last-quarter revenue ($2.1B vs $1.3B, roughly 1.6× Dexcom). Ovintiv Inc. runs the higher net margin — 46.1% vs 21.2%, a 24.8% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs -6.0%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs -7.2%).
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
Ovintiv Inc. is a U.S. petroleum company based in Denver. The company was formed in 2020 through a restructuring of its Canadian predecessor, Encana.
DXCM vs OVV — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $2.1B |
| Net Profit | $267.3M | $946.0M |
| Gross Margin | 62.9% | — |
| Operating Margin | 25.6% | 21.2% |
| Net Margin | 21.2% | 46.1% |
| Revenue YoY | 21.6% | -6.0% |
| Net Profit YoY | 153.6% | 1676.7% |
| EPS (diluted) | $0.67 | $3.64 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $2.1B | ||
| Q3 25 | $1.2B | $2.0B | ||
| Q2 25 | $1.2B | $2.2B | ||
| Q1 25 | $1.0B | $2.4B | ||
| Q4 24 | $1.1B | $2.2B | ||
| Q3 24 | $994.2M | $2.2B | ||
| Q2 24 | $1.0B | $2.2B |
| Q1 26 | $267.3M | — | ||
| Q4 25 | $267.3M | $946.0M | ||
| Q3 25 | $283.8M | $148.0M | ||
| Q2 25 | $179.8M | $307.0M | ||
| Q1 25 | $105.4M | $-159.0M | ||
| Q4 24 | $151.7M | $-60.0M | ||
| Q3 24 | $134.6M | $507.0M | ||
| Q2 24 | $143.5M | $340.0M |
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | — | ||
| Q3 25 | 60.5% | — | ||
| Q2 25 | 59.5% | — | ||
| Q1 25 | 56.9% | — | ||
| Q4 24 | 58.9% | — | ||
| Q3 24 | 59.7% | — | ||
| Q2 24 | 62.4% | — |
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | 21.2% | ||
| Q3 25 | 20.1% | 13.5% | ||
| Q2 25 | 18.4% | 23.1% | ||
| Q1 25 | 12.9% | -3.7% | ||
| Q4 24 | 17.0% | 0.1% | ||
| Q3 24 | 15.3% | 24.2% | ||
| Q2 24 | 15.7% | 25.4% |
| Q1 26 | 21.2% | — | ||
| Q4 25 | 21.2% | 46.1% | ||
| Q3 25 | 23.5% | 7.3% | ||
| Q2 25 | 15.5% | 13.9% | ||
| Q1 25 | 10.2% | -6.7% | ||
| Q4 24 | 13.6% | -2.7% | ||
| Q3 24 | 13.5% | 23.3% | ||
| Q2 24 | 14.3% | 15.5% |
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | $3.64 | ||
| Q3 25 | $0.70 | $0.57 | ||
| Q2 25 | $0.45 | $1.18 | ||
| Q1 25 | $0.27 | $-0.61 | ||
| Q4 24 | $0.37 | $-0.22 | ||
| Q3 24 | $0.34 | $1.92 | ||
| Q2 24 | $0.35 | $1.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $917.7M | $280.0M |
| Total DebtLower is stronger | — | $5.2B |
| Stockholders' EquityBook value | $2.7B | $11.2B |
| Total Assets | $6.3B | $20.4B |
| Debt / EquityLower = less leverage | — | 0.46× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | $280.0M | ||
| Q3 25 | $1.8B | $25.0M | ||
| Q2 25 | $1.2B | $20.0M | ||
| Q1 25 | $904.9M | $8.0M | ||
| Q4 24 | $606.1M | $42.0M | ||
| Q3 24 | $621.2M | $9.0M | ||
| Q2 24 | $939.2M | $8.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | $5.2B | ||
| Q3 25 | — | $5.2B | ||
| Q2 25 | — | $5.3B | ||
| Q1 25 | — | $5.5B | ||
| Q4 24 | — | $5.5B | ||
| Q3 24 | — | $5.9B | ||
| Q2 24 | — | $6.1B |
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $11.2B | ||
| Q3 25 | $2.7B | $10.2B | ||
| Q2 25 | $2.6B | $10.4B | ||
| Q1 25 | $2.3B | $10.1B | ||
| Q4 24 | $2.1B | $10.3B | ||
| Q3 24 | $2.0B | $10.7B | ||
| Q2 24 | $2.4B | $10.3B |
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | $20.4B | ||
| Q3 25 | $7.5B | $19.4B | ||
| Q2 25 | $7.3B | $19.7B | ||
| Q1 25 | $6.8B | $19.6B | ||
| Q4 24 | $6.5B | $19.3B | ||
| Q3 24 | $6.4B | $19.9B | ||
| Q2 24 | $6.8B | $19.8B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.46× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | 0.55× | ||
| Q4 24 | — | 0.53× | ||
| Q3 24 | — | 0.55× | ||
| Q2 24 | — | 0.59× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $954.0M |
| Free Cash FlowOCF − Capex | — | $489.0M |
| FCF MarginFCF / Revenue | — | 23.8% |
| Capex IntensityCapex / Revenue | — | 22.6% |
| Cash ConversionOCF / Net Profit | — | 1.01× |
| TTM Free Cash FlowTrailing 4 quarters | — | $1.5B |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $294.0M | $954.0M | ||
| Q3 25 | $659.9M | $812.0M | ||
| Q2 25 | $303.0M | $1.0B | ||
| Q1 25 | $183.8M | $873.0M | ||
| Q4 24 | $301.4M | $1.0B | ||
| Q3 24 | $199.5M | $1.0B | ||
| Q2 24 | $279.4M | $1.0B |
| Q1 26 | — | — | ||
| Q4 25 | $192.1M | $489.0M | ||
| Q3 25 | $579.4M | $268.0M | ||
| Q2 25 | $208.9M | $492.0M | ||
| Q1 25 | $96.8M | $256.0M | ||
| Q4 24 | $176.8M | $468.0M | ||
| Q3 24 | $88.3M | $484.0M | ||
| Q2 24 | $213.3M | $398.0M |
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | 23.8% | ||
| Q3 25 | 47.9% | 13.3% | ||
| Q2 25 | 18.1% | 22.2% | ||
| Q1 25 | 9.3% | 10.8% | ||
| Q4 24 | 15.9% | 21.4% | ||
| Q3 24 | 8.9% | 22.2% | ||
| Q2 24 | 21.2% | 18.1% |
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | 22.6% | ||
| Q3 25 | 6.7% | 26.9% | ||
| Q2 25 | 8.1% | 23.5% | ||
| Q1 25 | 8.4% | 26.0% | ||
| Q4 24 | 11.2% | 25.3% | ||
| Q3 24 | 11.2% | 24.7% | ||
| Q2 24 | 6.6% | 28.4% |
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | 1.01× | ||
| Q3 25 | 2.33× | 5.49× | ||
| Q2 25 | 1.69× | 3.30× | ||
| Q1 25 | 1.74× | — | ||
| Q4 24 | 1.99× | — | ||
| Q3 24 | 1.48× | 2.02× | ||
| Q2 24 | 1.95× | 3.00× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DXCM
Segment breakdown not available.
OVV
| Product And Service Revenue | $1.7B | 84% |
| Sales Of Purchased Product | $338.0M | 16% |
